Alessandro M Vannucchi Selected Research

Multiple Myeloma

1/2023	Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
11/2021	Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study.
1/2021	Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis.
3/2005	Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro M Vannucchi Research Topics

Disease

99	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 06/2004
58	Neoplasms (Cancer) 12/2023 - 05/2002
53	Polycythemia Vera 12/2023 - 09/2005
40	Essential Thrombocythemia 01/2023 - 09/2005
29	Splenomegaly 12/2023 - 12/2007
23	Thrombosis (Thrombus) 01/2024 - 08/2007
21	Thrombocytopenia (Thrombopenia) 04/2024 - 03/2012
21	Anemia 11/2023 - 01/2011
10	Leukemia 11/2023 - 05/2002
8	Pruritus (Itching) 12/2021 - 12/2007
7	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 07/2012
7	Thrombocytosis (Thrombocythemia) 07/2022 - 08/2007
7	Hemorrhage 01/2022 - 01/2008
6	Fibrosis (Cirrhosis) 11/2023 - 05/2009
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2009
4	Multiple Myeloma 01/2023 - 03/2005
4	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 01/2015
4	Disease Progression 01/2020 - 07/2011
4	Leukocytosis (Pleocytosis) 01/2020 - 05/2012
4	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 09/2008
4	Fatigue 01/2017 - 07/2011
3	Pneumonia (Pneumonitis) 09/2023 - 05/2017
3	Cytopenia 01/2023 - 06/2016
3	Systemic Mastocytosis 01/2023 - 12/2021
3	Polycythemia (Erythrocytosis) 01/2020 - 08/2007
3	Infections 01/2020 - 01/2015
3	Pain (Aches) 01/2017 - 07/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 06/2021
2	Blast Crisis (Blast Phase) 01/2023 - 01/2021
2	Eosinophilia 01/2023 - 06/2021
2	Portal Hypertension 01/2022 - 02/2011
2	Inflammation (Inflammations) 12/2018 - 02/2011
2	Sepsis (Septicemia) 02/2018 - 05/2017
2	Heart Failure 05/2017 - 07/2010
2	Fever (Fevers) 05/2017 - 07/2013
2	Hyperplasia 04/2014 - 05/2009
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 07/2010 - 12/2009
1	Hodgkin Disease (Hodgkin's Disease) 03/2024
1	Asthenia 09/2023
1	Enteritis 09/2023

Drug/Important Bio-Agent (IBA)

58	ruxolitinibIBA 12/2023 - 03/2012
24	Janus Kinase InhibitorsIBA 12/2023 - 12/2013
23	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 08/2010
15	Janus KinasesIBA 09/2023 - 11/2010
13	Hemoglobins (Hemoglobin)IBA 11/2023 - 05/2002
10	CalreticulinIBA 01/2019 - 03/2014
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 01/2007
9	fedratinibIBA 01/2023 - 08/2015
9	Janus Kinase 2IBA 05/2021 - 08/2007
8	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 11/2023 - 02/2018
7	CytokinesIBA 01/2020 - 12/2004
7	Syntex adjuvant formulationIBA 12/2017 - 07/2011
6	Janus Kinase 1IBA 11/2023 - 12/2012
6	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2007
5	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 04/2024 - 05/2017
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2011
5	InterferonsIBA 12/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2009
4	imetelstatIBA 12/2022 - 10/2021
4	givinostatIBA 01/2021 - 08/2010
4	Thrombopoietin (c-mpl Ligand)IBA 01/2020 - 06/2004
4	Everolimus FDA Link 11/2017 - 08/2011
4	Immunologic Factors (Immunomodulators)IBA 01/2017 - 02/2011
4	Reticulin (Reticular Fiber)IBA 04/2014 - 05/2009
3	activin AIBA 11/2023 - 01/2023
3	Danazol (Azol)FDA LinkGeneric 11/2023 - 01/2023
3	avapritinibIBA 01/2023 - 12/2021
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2022 - 10/2021
3	AnticoagulantsIBA 10/2021 - 03/2008
3	Phosphotransferases (Kinase)IBA 10/2021 - 12/2013
3	pomalidomideIBA 01/2021 - 01/2011
3	Histone Deacetylase InhibitorsIBA 01/2020 - 08/2010
3	anagrelide (Agrylin)FDA LinkGeneric 01/2017 - 12/2011
3	Erythropoietin FDA Link 04/2014 - 06/2011
3	Imatinib Mesylate (Gleevec)FDA Link 11/2010 - 12/2009
2	Circular RNAIBA 11/2023 - 01/2019
2	venetoclaxIBA 01/2023 - 01/2021
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 06/2021
2	IronIBA 01/2023 - 01/2017
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2021
2	Decitabine FDA Link 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 11/2016
2	Interleukin-3 (Interleukin 3)IBA 01/2020 - 11/2009
2	Thrombopoietin ReceptorsIBA 01/2020 - 12/2010
2	Dihydrotachysterol (AT 10)IBA 01/2019 - 08/2011
2	RNA (Ribonucleic Acid)IBA 01/2015 - 03/2012
2	Messenger RNA (mRNA)IBA 09/2014 - 11/2009
2	TOR Serine-Threonine KinasesIBA 01/2013 - 07/2011
2	bepafantIBA 10/2009 - 05/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024
1	ABO Blood-Group SystemIBA 01/2023

Therapy/Procedure

60	Therapeutics 01/2024 - 05/2002
5	Splenectomy 01/2021 - 12/2007
3	Stem Cell Transplantation 12/2023 - 03/2009
3	Drug Therapy (Chemotherapy) 10/2018 - 08/2007
3	Erythrocyte Transfusion 02/2018 - 01/2017
2	Autologous Transplantation 01/2023 - 12/2007
2	Precision Medicine 11/2022 - 01/2017
2	Hematopoietic Stem Cell Transplantation 01/2020 - 08/2014
2	Drug Tapering 02/2018 - 03/2012